Notice2021-13120
Advisory Committee on Immunization Practices (ACIP); Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 23, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment. The meeting will be webcast live via the World Wide Web; for more information on ACIP please visit the ACIP website: http:/ /www.cdc.gov/vaccines/acip/index.html.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 118 (Wednesday, June 23, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 118 (Wednesday, June 23, 2021)]
[Notices]
[Pages 32933-32934]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-13120]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2021-0034]
Advisory Committee on Immunization Practices (ACIP); Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the Advisory
Committee on Immunization Practices (ACIP); June 23, 2021 and June 24,
2021, 9:00 a.m.-5:30 p.m., EDT (times subject to change), in the
original FRN.
The virtual meeting was published in the Federal Register on
Monday, April 5, 2021, Volume 86, Number 63, page 17606.
The virtual meeting is being amended to add an additional date,
June 25, 2021 and time, update meeting times and supplemental
information and should read as follows:
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), announces the
following meeting of the Advisory Committee on Immunization Practices
(ACIP). This meeting is open to the public. Time will be available for
public comment. The meeting will be webcast live via the World Wide
Web; for more information on ACIP please visit the ACIP website: <a href="http://www.cdc.gov/vaccines/acip/index.html">http://www.cdc.gov/vaccines/acip/index.html</a>.
DATES: The meeting will be held on June 23, 2021, from 10:00 a.m. to
5:00 p.m., EDT (times subject to change); June 24, 2021, from 10:30
a.m. to 5:10 p.m., EDT (times subject to change); and June 25, 2021,
from 10:00 a.m. to 12:20 p.m., EDT (times subject to change). Written
comments must be received on or before June 25, 2021.
A notice of this ACIP meeting has also been posted on CDC's ACIP
website at: <a href="http://www.cdc.gov/vaccines/acip/index.html">http://www.cdc.gov/vaccines/acip/index.html</a>. In addition,
CDC has sent notice of this ACIP meeting by email to those who
subscribe to receive email updates about ACIP.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee
Management Specialist, Centers for Disease Control and Prevention,
National Center for Immunization and Respiratory Diseases, 1600 Clifton
Road NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367;
Email: <a href="/cdn-cgi/l/email-protection#1c5d5f554c5c7f787f327b736a"><span class="__cf_email__" data-cfemail="0342404a53436067602d646c75">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged with advising the Director, CDC,
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s,
the committee is mandated to establish and periodically review and, as
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program,
along with schedules regarding dosing interval, dosage, and
contraindications to administration of vaccines. Further, under
provisions of the Affordable Care Act, section 2713 of the Public
Health Service Act, immunization recommendations of the ACIP that have
been approved by the Director of the Centers for Disease Control and
Prevention and appear on CDC immunization schedules must be covered by
applicable health plans.
Matters to be Considered: The agenda will include discussions on
cholera
[[Page 32934]]
vaccine, dengue vaccine, ebola vaccine, hepatitis vaccines, herpes
zoster vaccines, influenza vaccines, orthopoxvirus vaccine,
pneumococcal vaccine, rabies vaccine and tickborne encephalitis
vaccine. Recommendation votes on dengue vaccine, ebola vaccine,
influenza vaccines and rabies vaccine are scheduled. Vaccines for
Children (VFC) votes on dengue vaccine and influenza vaccines are
scheduled. Agenda items are subject to change as priorities dictate.
For more information on the meeting agenda visit <a href="https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html">https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html</a>.
Meeting Information: The meeting will be webcast live via the World
Wide Web; for more information on ACIP please visit the ACIP website:
<a href="http://www.cdc.gov/vaccines/acip/index.html">http://www.cdc.gov/vaccines/acip/index.html</a>.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted into the docket.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Oral public comment will occur
before any scheduled votes including all votes relevant to the ACIP's
Affordable Care Act and Vaccines for Children Program roles. Priority
will be given to individuals who submit a request to make an oral
public comment before the meeting according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the June 23-25, 2021, ACIP meeting must
submit a request at <a href="http://www.cdc.gov/vaccines/acip/meetings/">http://www.cdc.gov/vaccines/acip/meetings/</a> no later
than 11:59 p.m., EDT, June 18, 2021, according to the instructions
provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
lottery to determine the speakers for the scheduled public comment
session. CDC staff will notify individuals regarding their request to
speak by email by June 21, 2021. To accommodate the significant
interest in participation in the oral public comment session of ACIP
meetings, each speaker will be limited to 3 minutes, and each speaker
may only speak once per meeting.
Written Public Comment: The docket will be opened to receive
written comments on June 1, 2021. Written comments must be received on
or before June 25, 2021.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-13120 Filed 6-22-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 23, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.